Galectin Therapeutics | GALT - Laba Sebelum Pajak





Laba Sebelum Pajak Perubahan Tanggal
AbbVie USD 7.61B 2.04B 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Galectin Therapeutics USD -12.37M 880K 2024-06
Gilead Sciences USD -7.53B 10.11B 2026-06
Immunic USD -19.3M 6.28M 2025-12
Incyte USD 751.51M 407.91M 2026-06
Merck USD -3.53B 6.95B 2026-03